COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-546X

Online ISSN:-2394-5478


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 602

Emailed: 0

PDF Downloaded: 317

Indian Journal of Microbiology Research

Biomarkers improves prognostic and mortality prediction in pneumonia

Full Text PDF Share on Facebook Share on Twitter

Author Details : D Danis Vijay, S Jayanthi*, N Meenakshi

Volume : 5, Issue : 4, Year : 2018

Article Page : 430-435

Suggest article by email


Pneumonia exhibits mortality rates, between 20% and 50% in severe cases. Biomarkers are useful tools for antibiotic therapy modifications as well as diagnosis, prognosis and follow-up treatment of pneumonia. This review presents the biological and clinical features of various biomarkers in Pneumonia patients, including C-reactive protein, Procalcitonin, Coceptin, D-dimers, MRpro-ADM, (Mid-regional pro adrenomedullin), Corisol, Endothelin-1, Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1), Adrenomedullin, Endotoxin, Mid regional Pro-Atrial Natriuretic Peptide (MR-proANP), TNF-? Polymorphisms, Pentraxin 3.

Keywords: Pneumonia, Community-acquired, Hospital-acquired, Ventilator-associated pneumonia (VAP), Biomarkers, Point of care testing.

Doi : 10.18231/2394-5478.2018.0089

How to cite : Vijay D D, Jayanthi S, Meenakshi N, Biomarkers improves prognostic and mortality prediction in pneumonia. Indian J Microbiol Res 2018;5(4):430-435

Copyright © 2018 by author(s) and Indian J Microbiol Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (